Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012

Plasmodium falciparum in Asymptomatic Immigrants from Sub-Saharan Africa, Spain

Cite This Article

To the Editor: A range of infectious diseases have been described in asymptomatic immigrants (1), which may justify the implementation of screening after obtaining consent. In particular, asymptomatic malaria caused by Plasmodium falciparum parasitemia among recently arrived immigrants may be a major public health problem outside malaria-endemic areas because these patients may be involved in autochthonous transmission cycles and may act as reservoirs capable of reintroducing malaria into areas where it had been previously eradicated.

In 2010, we reviewed the medical records of 314 asymptomatic (defined as patients with no symptoms at the time of consultation) immigrants from sub-Saharan Africa who had settled in Spain, had not traveled to their countries of origin since arrival, and had been examined at the Tropical Medicine Unit (TMU) of the Ramon y Cajal Hospital in Madrid during the previous 5 years. Systematic screening included a blood count; serum biochemistry; basic urine analysis; serologic tests for HIV infection, hepatitis B or C infection, syphilis, and schistosomiasis (if epidemiologic risk factors were present); tuberculin skin test; analysis of fecal samples for parasites; and PCR to identify Plasmodium spp (2). Date of arrival in Spain was obtained from the patient and corroborated by the nongovernmental organizations caring for them.

PCR for Plasmodium spp. was performed for 216 patients, and 10 (4.6%) had positive test results for P. falciparum. Nine were men; median age was 27 years (interquartile range [IQR] 20–31 years). The median period from arrival in Spain to malaria diagnosis was 4.5 months (IQR 1.75–12.5 months). Three men received a diagnosis of P. falciparum malaria >1 year after arrival.

Patient 1 was a 32-year-old man from Angola who came to the TMU for screening 13 months after arriving in Spain. He was treated with a standard regimen of artesunate plus sulfadoxine/pyrimethamine; latent tuberculosis (TB) infection and schistosomiasis were also diagnosed. Patient 2 was a 17-year-old man from Senegal, seen at the TMU 14 months after arrival. Malaria treatment was not prescribed because he was lost to follow-up. He was also diagnosed with latent TB infection. Patient 3 was a 28-year-old man from Guinea who visited the TMU 28 months after arrival in Spain. He was treated with a standard regimen of atovaquone/proguanil and also received diagnoses of tuberculosis (TB) infection, schistosomiasis, and strongyloidiasis. No statistically significant association was observed between positive or negative PCR for P. falciparum and a diagnosis of tuberculosis (TB) infection, hepatitis B or C virus infection, HIV infection, syphilis, intestinal parasite infection, or schistosomiasis. None of the 3 patients had received a blood transfusion since arriving in Spain.

Reported prevalence of imported malaria among immigrants may be >10%, according to some studies (1), with higher rates among persons from sub-Saharan Africa (malaria caused by P. falciparum occurring mainly 3 months after arrival). Clinical symptoms of malaria in immigrants are typically mild, with low levels of parasitemia. Many immigrants may be asymptomatic (1,3), which has been explained by partial immunity acquired gradually after prolonged exposure in areas with stable malaria transmission. Because infected persons may initially have no symptoms, implementation of malaria screening for recently arrived immigrants from disease-endemic areas would seem advisable (4).

How long a low level of P. falciparum parasitemia may persist once exposure to malaria has been discontinued is not known. Mathematical models have estimated the maximum duration of P. falciparum infection after interruption of transmission at ≈4 years (5), although delayed clinical presentations of P. falciparum malaria have been described as long as 2 (6), 4 (7), or even 8 years (8) after patients have left malaria-endemic areas. These data highlight that low asymptomatic parasitemia may persist long after migration.

Determining in which patients with asymptomatic parasitemia clinical malaria will develop and when, or if, any external factors may act as triggers would also be useful. A study in France found that 2.3% of malaria cases among immigrants developed >1 year after their arrival and that pregnancy and co-infection with HIV were factors associated with late presentation of malaria caused by P. falciparum (9).

Asymptomatic malaria cases may affect public health in non–disease-endemic areas because persons with low-grade parasitemia are capable of infecting mosquitoes (10). These persons could act as unidentified reservoirs and contribute to transmission in areas where malaria has been eliminated. In addition, congenital transmission or transmission by blood transfusion or organ transplantation may occur even when the donor has lived for years outside the malaria-endemic area.

Our cases highlight how malaria parasites may persist in asymptomatic immigrants long after their arrival in the host country (up to 28 months). On the basis of published reports of symptomatic delayed cases, we believe that the prevalence of persistently low-level parasitemia among asymptomatic immigrants is probably higher than previous estimates. Screening for malaria among immigrants long after arrival would help determine if there are any factors that influence the development of clinical malaria. Delayed screening could also be particularly relevant in certain risk groups, such as pregnant women and persons who are HIV positive. As a public health measure, such delayed screening could play a role in preventing outbreaks or reintroducing malaria in countries where it has been eradicated.



We thank L. Velásquez for technical assistance and help with the database.

Support was provided by the Red de Investigación de Centros de Enfermedades Tropicales (RICET). RD 06/0021/0020.


Begoña Monge-Maillo, Francesca Norman, José Antonio Pérez-Molina, Marta Díaz-Menéndez, Jose Miguel Rubio, and Rogelio López-VélezComments to Author 
Author affiliations: Ramón y Cajal Hospital. Madrid, Spain (B. Monge-Maillo, F. Norman, J.A. Pérez-Molina, M. Díaz-Menéndez, R. López-Vélez); National Centre of Microbiology, Madrid (J.M. Rubio)



  1. Monge-Maillo  B, Jimenez  BC, Perez-Molina  JA, Norman  F, Navarro  M, Perez-Ayala  A, Imported infectious diseases in mobile populations, Spain. Emerg Infect Dis. 2009;15:174552.PubMedGoogle Scholar
  2. Rubio  JM, Post  RJ, van Leeuwen  WM, Henry  MC, Lindergard  G, Hommel  M. Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg. 2002;96:S199204. DOIPubMedGoogle Scholar
  3. Mascarello  M, Gobbi  F, Angheben  A, Concia  E, Marocco  S, Anselmi  M, Imported malaria in immigrants to Italy: a changing pattern observed in north eastern Italy. J Travel Med. 2009;16:31721. DOIPubMedGoogle Scholar
  4. Monge-Maillo  B, Lopez-Velez  R. Is screening for malaria necessary among asymptomatic refugees and immigrants coming from endemic countries? Expert Rev Anti Infect Ther. 2011;9:5214. DOIPubMedGoogle Scholar
  5. Sama  W, Killeen  GF, Smith  T. Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hyg. 2004;70:62534.PubMedGoogle Scholar
  6. Krajden  S, Panisko  DM, Tobe  B, Yang  J, Keystone  JS. Prolonged infection with Plasmodium falciparum in a semi-immune patient. Trans R Soc Trop Med Hyg. 1991;85:7312. DOIPubMedGoogle Scholar
  7. Greenwood  T, Vikerfors  T, Sjoberg  M, Skeppner  G, Farnert  A. Febrile Plasmodium falciparum malaria 4 years after exposure in a man with sickle cell disease. Clin Infect Dis. 2008;47:e3941. DOIPubMedGoogle Scholar
  8. Szmitko  PE, Kohn  ML, Simor  AE. Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagn Microbiol Infect Dis. 2009;63:1057. DOIPubMedGoogle Scholar
  9. D’Ortenzio  E, Godineau  N, Fontanet  A, Houze  S, Bouchaud  O, Matheron  S, Prolonged Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis. 2008;14:3236. DOIPubMedGoogle Scholar
  10. Schneider  P, Bousema  JT, Gouagna  LC, Otieno  S, van de Vegte-Bolmer  M, Omar  SA, Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007;76:4704.PubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid1802.111283

Related Links


Table of Contents – Volume 18, Number 2—February 2012

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Rogelio López-Vélez, Tropical Medicine and Clinical Parasitology, Infectious Diseases Department, Ramón y Cajal Hospital, Carretera de Colmenar Km 9,1, Madrid 28034, Spain

Send To

10000 character(s) remaining.


Page created: January 24, 2012
Page updated: January 24, 2012
Page reviewed: January 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.